InterVenn is leveraging an AI-powered clinical technology for glycoproteomics to transform healthcare.
Leadership
Joshua Stahl
Fund
SVF2
Status
Private
Sector
Health Tech
Region
Americas
InterVenn is leveraging an AI-powered clinical technology for glycoproteomics to transform healthcare.